Science:Natural Sciences
COVID-19 continues to pose major problems in the winter in the USA. Infections and hospitalizations are increasing and there is a fear of emergence of new variants. Therapeutic tools are also evolving. We discuss these new developments!
Watch the video version via: https://youtu.be/ElnahBl53e8
Topics discussed:- The latest facts on COVID
- Current therapeutic approaches including antivirals and monoclonal antibodies
- Future perspectives for the coming year on COVID-19.
- Adarsh Bhimraj, MD. Director of Education and Fellowships, Division of Infectious Diseases, Houston Methodsit Hospital. Chair IDSA Guidelines for COVID-19.
This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias.
AAC is available at https://asm.org/aac.
Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.
Subscribe to the podcast at https://asm.org/eic
More Episodes
The Launch of ASM Case Reports Journal
2024-10-11
2024-10-11
Why Phage Therapy May Fail
2024-04-05
2024-04-05
Is Lophomonas a Pathogen?
2024-02-23
2024-02-23
New Antifungals (AAC ed.)
2023-11-10
2023-11-10
A Novel Coccidioides Antibody LFA (JCM ed.)
2023-10-20
2023-10-20
Viral Outbreaks in the Headlines (JCM ed.)
2023-08-18
2023-08-18
Get this podcast on your
phone, FREE
